Dr. Chris Yu is the co-founder and CEO of Anpac Bio. He is a highly successful business executive, innovative engineer, and pioneering inventor, filing over 200 patent applications (and earning over 100 to date). A proven, serial entrepreneur, Dr. Yu has consistently delivered solid returns to investors (over 100X and 30X respectively in two start-up companies).
Over his 20-year career, Dr. Yu’s innovative and profitable work has spanned the fields of medical devices for cancer screening, biology (bio-membranes), signal detection, transducer design and fabrications, reagents, IC materials, and integrated circuits, among many other technologies.
Dr. Yu’s experience includes leadership in three Fortune 500 companies, including Motorola, before launching his own successful start-up companies. As Research & Development Director for one NYSE listed company, he was instrumental in building a small division into a highly successful technology company with more than $200 million in revenue, and a lucrative NSDAQ IPO. Throughout his career, the innovative high-tech products he helped develop have achieved over $3 billion in revenue to date.